1. Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG). https://isoponline.org/special-interest-groups/risk-communication-group/. Accessed 19 Sept 2020.
2. Erice Declaration: effective communications in pharmacovigilance (report of the International Conference on Developing Effective Communications in Pharmacovigilance held in Erice, 24-27 September 1997, organised by the Uppsala Monitoring Centre (UMC), the Clinical Pharmacology Unit of Verona University, the International School of Pharmacology of the Ettore Majorana Centre for Scientific Culture in Erice, Italy and the World Health Organization, and supported by EQUUS Communications, London). Uppsala: UMC; 1997.
3. Statement E. communication, medicines and patient safety (report of the Workshop on Drug Risk Communication held in Erice, 3–8 July 2009, organised by the International School of Pharmacology at the Ettore Majorana Foundation and Centre for Scientific Culture in Erice, Italy, in collaboration with the International Society of Pharmacovigilance (ISoP), the SK Foundation and the Uppsala Monitoring Centre (UMC)). Br J Clin Pharmacol. 2009;2010(69):207–8.
4. Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG; on behalf of the ISoP CommSIG. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance. Drug Saf. 2015; 38:621–27.
5. 14th Annual Meeting of ISoP. https://isoponline.org/annual-meetings/isop-2014-annual-meeting/. Accessed 30 Jan 2022.